In recent years, PCK2 has been abnormally expressed in a variety of cancers, such as liver cancer, colorectal cancer, lung cancer, melanoma and prostate cancer, which is closely related to the occurrence and development of cancer [53,54,55,56,57]. This evidence concerns the gene PCK2 and prostate carcinoma.